Speaker illustration

Mr Carlos Galan

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

Member of:

European Society of Cardiology

Cardiac pressure overload exposes hidden anthracycline-induced cardiotoxicity: Results from a preclinical large-animal trial

Event: ESC Congress 2022

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure - Cardiotoxicity of drugs

Thumbnail

Remote ischemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity: results from a randomized preclinical trial in pigs

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure

Session: Cellular Pathomechanisms in Heart Failure

Thumbnail

Microcirculation injury is involved in anthracycline-induced cardiac toxicity

Event: ESC CONGRESS 2019

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Vascular remodelling from capillaries to aorta

Thumbnail

Early microcirculation impairment in a pig model of anthracycline cardiotoxicity: evaluation by cardiac magnetic resonance and coronary physiology assessment

Event: ESC Congress 2018

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure – Pathophysiology and mechanisms

Thumbnail

Anthracycline cardiotoxicity in the hypertrophic heart: testing a dual-hit hypothesis

Event: ESC Congress 2018

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure – Pathophysiology and mechanisms

Thumbnail

Early diagnosis of anthracycline induced cardiotoxicity in a swine model by serial multiparametric cardiac magnetic resonance.

Event: ESC CONGRESS 2017

Topic: Cardiotoxicity of drugs

Session: Chronic heart failure (CHF)

Thumbnail

This platform is supported by

logo Novo Nordisk